Investing Profile
David H. Crean(114)
CEOVCInvestorAdvisor
General Partner at 1004 Venture Partners
San Diego, California
Your Intro Paths to David H. Crean
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →David H. Crean's investing connections
4 Investors
Connected to Alfred Lin (Sequoia Capital), Tim Chang (Mayfield Fund), Alex Kopelyan (SOSV), and 1 other investor on Signal.
Networks David H. is a member of
Robyn Frankel Network
147 CONNECTIONS
Robyn Frankel Network
147 CONNECTIONS
Robyn Frankel Network
147 CONNECTIONS
Robyn Frankel Network
147 CONNECTIONS
iCiDIGITAL Network
86 CONNECTIONS
Find David H. Crean on
cbCurrent Investing Position
1004 Venture Partners General Partner
Investment Range
$250K - $10.0M
Sweet Spot
$500K
David H. Crean is on these Sector & Stage Rankings
Diverse InvestorsPharmaceuticals (Seed)Investors who invested in diverse foundersPharmaceuticals (Series A)BioTech (Series A)Pharmaceuticals (Pre-seed)BioTech (Pre-seed)Therapeutics (Seed)Investors who invested in female foundersLos Angeles / Southern CaliforniaInvestors who were foundersDiagnostics (Seed)Drug Delivery (Seed)Diagnostics (Series A)Drug Delivery (Series A)Diagnostics (Pre-seed)Drug Delivery (Pre-seed)Therapeutics (Series A)BioTech (Seed)Therapeutics (Pre-seed)
most interested in
-Neurodegeneration (Alzheimer's/ Dementia, ALS, Parkinson's Huntinton's) -Therapeutic approaches: Vaccines, Antibodies, Small molecules, peptides, RNA -Companion Diagnosticsnot interested in
Medical devicesDavid H. Crean's Experience
General Partner 1004 Venture PartnersPresent
Chief Business Officer MediciNova, Inc.Present
Co-Founder and Chair CEOthreesixtyPresent
Venture Partner LemVega™ Biotech Venture FundPresent
Co-Chair, CEO Roundtable Connection - Life Sciences Procopio, Cory, Hargreaves & Savitch LLPPresent
Member Board of Directors Cenna BiosciencesPresent
Chairman of the Board Paracrine, Inc.Present
Board of Governor's | Chairman, Capital Development BiocomPresent
Member Board of Directors Almon TherapeuticsPresent
Chief Business Officer ImmunogenXPresent
Lead Independent Director, Audit and Scientific Committees HistogenPresent
Chairman Of The Board Of Directors HistogenPresent
Audit Committee Chair; Governance and Compensation Committees HistogenPresent
Venture Member, Cohort 2 Venture InstitutePresent
Chair, CEO Circle, Life Sciences and Healthcare Association For Corporate Growth - Acg San DiegoPresent
Contributing Author, Forbes.com Forbes Los Angeles Business CouncilPresent
Member, CEO Forum REFPresent
Partner 1004 Venture PartnersPresent
Co-Founder and Forum Leader CEOthreesixtyPresent
Venture Partner VU Venture PartnersPresent
Member Board of Directors California Life Sciences (CLS)Present
Chair, CEO Roundtable Connection - Life Sciences Procopio, Cory, Hargreaves & Savitch LLPPresent
Chief Executive Officer Lenire BiosciencesPresent
Chairman, Independent Member, Board Of Directors Phoenix Molecular DesignsPresent
Senior Advisor Objective Capital Partners, LLCPresent
Managing Director Objective Capital Partners, LLCPresent
President, Board Of Directors Association For Corporate Growth - Acg San DiegoPresent
Member Board of Directors ConnectPresent
Chief Business Officer iCiDIGITALPresent
Member Board of Directors Paracrine, Inc.Present
Chief Executive Officer iCiDIGITALPresent
Senior Advisor Objective, Investment Banking & ValuationPresent
Managing Director Objective, Investment Banking & ValuationPresent
Chief Executive Officer, Board of Directors Seagull FilmsPresent
Board Advisor iCiDIGITALPresent
Senior Manager, Medical Research iCiDIGITALPresent
Post-Doctoral Research Fellowship University of TorontoPresent
Post-Doctoral Research Fellowship ROSWELL PARK CANCER INSTITUTEPresent
Forum Leader - Life Sciences and Healthcare REFPresent
Co-Founder, Healthcare and Life Sciences CEOthreesixtyPresent
Chairman of the Board of Directors Paracrine, Inc.Present
Board of Governor's | Chairman, Capital Development (Partnering & Fundraising) BiocomPresent
Chief Business Officer, Head of Investor & Public Relations and Communications MediciNova, Inc.Present
Managing Partner Cardiff Advisory LLCPresent
Venture Partner 1004 Venture PartnersPresent
Chief Business Officer Robyn FrankelPresent
Chief Executive Officer Robyn FrankelPresent
Board Advisor Amydis, Inc.Present
Board Advisor Robyn FrankelPresent
Chief Business Officer Amydis, Inc.Present
Vice President, Corporate Development Aqua Pharmaceuticals, an Almirall CompanyPresent
Senior Director, Corporate Business Development AllerganPresent
Director, Project and Portfolio Management AllerganPresent
Senior Manager, Medical Research Robyn FrankelPresent
David H. Crean's Education
Canisius College Bachelor of Science (B.S.) PreMed & Sports Medicine
University at Buffalo Master of Science (M.S.) Natural Sciences / Oncology
State University of New York at Buffalo - School of Pharmacy and Pharmaceutical Sciences Doctor of Philosophy (Ph.D.) Biophysics
University at Buffalo Pharmacy and Pharmaceutical Sciences Doctor of Philosophy (Ph.D.) Biophysics
Pepperdine Graziadio Business School Master of Business Administration (MBA) Finance
Pepperdine University M.B.A. Finance
State University of New York at Buffalo Ph.D. Biophysics
State University of New York at Buffalo M.S. Oncology
Canisius College B.S. Pre-Medicine
Founders who looked at David H. Crean's profile also looked at these Scouts & Angels